Metabolic Liver Diseases — MCQs

10 questions

Which of the following statements about Wilson's disease is false?

Which one of the following diseases is classified as an autosomal dominant disorder?

A 50-year-old man with a history of alcohol abuse is found to have elevated liver enzymes, and a liver biopsy shows the microscopic features of steatosis. If the patient abstains from further drinking, this condition will most likely evolve into which of the following?

Which of the following is NOT included in the Child-Pugh criteria for assessing liver disease severity?

Earliest phenotypic manifestation of idiopathic hereditary hemochromatosis is:

The enzyme deficient in Galactosemia is:-

Intrahepatic cholestasis is seen in -

Micronodular cirrhosis is seen in all except:

Mallory bodies are typically seen in all of the following conditions except:

Q10

Which of the following conditions is associated with pathological copper pigmentation in the liver?

Metabolic Liver Diseases Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following statements about Wilson's disease is false?

A. Autosomal recessive
B. Serum ceruloplasmin level < 20 mg/dl
C. Urinary copper excretion < 100 micrograms/day (Correct Answer)
D. Zinc acetate is used as maintenance therapy

Explanation: ***Urinary copper excretion < 100 micrograms/day*** - A definitive diagnostic criterion for Wilson's disease is an **elevated 24-hour urinary copper excretion**, typically **greater than 100 µg/day** (or occasionally 40-100 μg/day in symptomatic patients). - Therefore, a value *less than 100 µg/day* would be considered a normal finding and would indicate that Wilson's disease is unlikely, making this statement false in the context of diagnosing the disease. *Autosomal recessive* - Wilson's disease is inherited in an **autosomal recessive pattern**, meaning an individual must inherit two copies of the mutated *ATP7B* gene (one from each parent) to develop the disease. - This characteristic inheritance pattern is fundamental to understanding the genetic basis of the disorder. *Serum ceruloplasmin level < 20 mg/dl* - **Low serum ceruloplasmin** (typically < 20 mg/dL) is a hallmark of Wilson's disease, as ceruloplasmin is the major copper-carrying protein in the blood, and its synthesis is impaired. - This low level indicates defective copper metabolism and transport, leading to copper accumulation. *Zinc acetate is used as maintenance therapy* - **Zinc acetate** (e.g., Galzin) is a commonly used maintenance therapy for Wilson's disease. - It works by inducing **metallothionein** in enterocytes, which sequesters dietary copper and prevents its absorption, thereby promoting fecal copper excretion.

Question 2: Which one of the following diseases is classified as an autosomal dominant disorder?

A. Hemochromatosis
B. Phenylketonuria
C. Maturity onset diabetes of the young (Correct Answer)
D. Glucose-6 phosphate dehydrogenase deficiency

Explanation: ***Maturity onset diabetes of the young*** - **Maturity onset diabetes of the young (MODY)** is a genetically heterogeneous group of single-gene disorders characterized by beta-cell dysfunction and impaired insulin secretion, typically inherited in an **autosomal dominant pattern** [1]. - A single copy of the mutated gene is sufficient to cause the condition, leading to diabetes usually before the age of 25, often without obesity or autoantibodies [1]. *Hemochromatosis* - **Hemochromatosis** is typically inherited in an **autosomal recessive pattern**, meaning two copies of the mutated gene (e.g., *HFE* gene) are required for the disease to manifest. - It leads to excessive iron absorption and tissue iron overload. *Phenylketonuria* - **Phenylketonuria (PKU)** is an **autosomal recessive disorder** caused by a deficiency in the enzyme **phenylalanine hydroxylase**, necessitating two mutated gene copies for the disease to occur. - This leads to the accumulation of phenylalanine, causing neurological damage if untreated. *Glucose-6 phosphate dehydrogenase deficiency* - **Glucose-6 phosphate dehydrogenase (G6PD) deficiency** is an **X-linked recessive disorder**, meaning the gene is located on the X chromosome and typically affects males more severely. - Females can be carriers, and hemizygous males (having only one X chromosome) will express the disorder if they inherit the mutated gene.

Question 3: A 50-year-old man with a history of alcohol abuse is found to have elevated liver enzymes, and a liver biopsy shows the microscopic features of steatosis. If the patient abstains from further drinking, this condition will most likely evolve into which of the following?

A. Acute liver injury
B. Chronic liver disease
C. Cirrhosis
D. Complete resolution (Correct Answer)

Explanation: ***Complete regression*** - Abstaining from alcohol can lead to **complete regression** of steatosis as the liver has a remarkable ability to heal and regenerate when inflammation is not present [1]. - With sustained abstinence, the liver enzymes can return to normal and the steatosis may resolve fully within months [1]. *Chronic hepatitis* - Chronic hepatitis is characterized by ongoing **inflammation** and potential liver damage, which is not typically seen when a patient successfully abstains from alcohol. - This condition usually occurs after prolonged liver injury, rather than as a direct evolution from steatosis with abstinence. *Acute hepatitis* - Acute hepatitis usually presents with **sudden onset of liver inflammation** often caused by viral infections or toxins, rather than alcoholic liver steatosis. - In the context of alcohol, acute hepatitis would indicate recent and severe liver damage, which differs when the patient avoids further alcohol. *Hyperplastic nodules* - Hyperplastic nodules are associated with advanced liver disease, often seen in conditions like **cirrhosis**, rather than directly evolving from steatosis after alcohol cessation. - These nodules develop as a compensatory response in chronic liver disease, which is not expected if the steatosis resolves.

Question 4: Which of the following is NOT included in the Child-Pugh criteria for assessing liver disease severity?

A. ALT / AST (Correct Answer)
B. S. albumin
C. Serum Bilirubin
D. Ascites

Explanation: ***ALT / AST*** - The Child-Pugh score primarily assesses the synthetic and excretory functions of the liver, not necessarily the degree of **hepatocellular inflammation** reflected by transaminases [3]. - While ALT/AST levels are crucial for diagnosing acute liver injury and monitoring chronic liver diseases, they are **not direct components** of the Child-Pugh class, which focuses on prognosis [1]. *S. albumin* - **Serum albumin** reflects the synthetic function of the liver, as albumin is exclusively produced by hepatocytes [2]. - Low albumin levels indicate significant **hepatic dysfunction**, which is directly incorporated into the Child-Pugh scoring system. *Serum Bilirubin* - **Serum bilirubin** measures the liver's ability to conjugate and excrete bilirubin, a key excretory function [2]. - Elevated bilirubin levels signify impaired liver function and are a critical parameter in the **Child-Pugh classification**. *Ascites* - The presence and severity of **ascites** are clinical signs of decompensated liver disease, reflecting portal hypertension and fluid retention [2]. - Ascites is a **clinical parameter** directly included in the Child-Pugh score, contributing to the assessment of disease severity.

Question 5: Earliest phenotypic manifestation of idiopathic hereditary hemochromatosis is:

A. Post-prandial increase in serum iron concentration
B. Increased transferrin saturation (Correct Answer)
C. Elevated serum ferritin level
D. Slate grey pigmentation of skin

Explanation: ***Increased transferrin saturation*** - **Increased transferrin saturation** is the **earliest phenotypic manifestation** of idiopathic hereditary hemochromatosis due to increased iron absorption exceeding the binding capacity of transferrin [1]. - This precedes significant iron overload and subsequent organ damage, making it a key diagnostic marker in early stages [3]. *Post-prandial increase in serum iron concentration* - While iron absorption is increased in hemochromatosis, a **post-prandial increase in serum iron** is a less specific and less consistently used marker for early diagnosis compared to transferrin saturation. - Serum iron levels can fluctuate significantly, making a single post-prandial measurement less reliable for detecting the initial stages of iron overload [2]. *Elevated serum ferritin level* - **Elevated serum ferritin** indicates total body iron stores and is a good marker for accumulated iron overload, but it usually rises later than transferrin saturation [3]. - Ferritin can also be an **acute phase reactant**, meaning it can be elevated in conditions other than hemochromatosis (e.g., inflammation, infection), making it less specific as an initial diagnostic marker [3]. *Slate grey pigmentation of skin* - **Slate grey pigmentation** is a late manifestation of hemochromatosis, indicating significant and prolonged iron deposition in the skin and other organs [1]. - This symptom suggests **advanced disease** and is not an early phenotypic expression.

Question 6: The enzyme deficient in Galactosemia is:-

A. Galactose-1-phosphate uridyltransferase (GALT) (Correct Answer)
B. Sphingomyelinase
C. Glucocerebrosidase
D. Hexosaminidase

Explanation: ***Galactose-1-phosphate uridyltransferase (GALT)*** - Deficiency of **GALT** leads to the accumulation of **galactose-1-phosphate** in tissues, which is toxic and causes the symptoms of **classical galactosemia**. - This enzyme is crucial for the second step in the Leloir pathway, converting **galactose-1-phosphate** and UDP-glucose into UDP-galactose and glucose-1-phosphate. *Sphingomyelinase (associated with Niemann-Pick disease)* - Deficiency in **sphingomyelinase** causes the accumulation of **sphingomyelin**, leading to **Niemann-Pick disease**, characterized by hepatosplenomegaly and neurological deterioration. - This enzyme is involved in the catabolism of lipids, distinct from carbohydrate metabolism. *Glucocerebrosidase (associated with Gaucher's disease)* - Deficiency of **glucocerebrosidase** results in the accumulation of **glucocerebroside**, leading to **Gaucher's disease**, which affects the spleen, liver, bone marrow, and sometimes the brain. - This is a lysosomal storage disorder involving glycosphingolipids, not galactose metabolism. *Hexosaminidase (associated with Tay-Sachs disease)* - Deficiency of **hexosaminidase A** causes the accumulation of **GM2 ganglioside**, resulting in **Tay-Sachs disease**, a severe neurodegenerative disorder. - This enzyme primarily functions in the breakdown of gangliosides, which are complex lipids, not galactose.

Question 7: Intrahepatic cholestasis is seen in -

A. Hypercalcemia
B. All of the options
C. Galactosemia
D. Haemochromatosis (Correct Answer)

Explanation: ***Haemochromatosis*** - **Haemochromatosis** is a hereditary disorder characterized by excessive iron absorption and deposition in multiple organs, including the liver [1]. - Iron accumulation in **hepatocytes** causes direct cellular injury and can lead to **intrahepatic cholestasis** as one of its hepatic manifestations [1]. - The progressive iron overload leads to **hepatic fibrosis** and eventually **cirrhosis**, with cholestatic features often present due to hepatocellular dysfunction [1]. - Clinical presentation includes hepatomegaly, elevated liver enzymes, and signs of chronic liver disease including cholestasis. *Galactosemia* - **Galactosemia** is an inherited metabolic disorder affecting galactose metabolism, leading to accumulation of galactose-1-phosphate. - While it causes significant **hepatocellular damage** and can progress to cirrhosis, the primary hepatic manifestation is **hepatocellular injury** rather than cholestasis. - The liver pathology typically shows fatty infiltration, hepatomegaly, and cirrhosis, but **intrahepatic cholestasis is not a characteristic feature** of galactosemia. *Hypercalcemia* - **Hypercalcemia** does not cause **intrahepatic cholestasis** as a primary manifestation. - Its hepatic effects are minimal and typically related to systemic complications or calcification, not direct cholestatic liver disease. *All of the options* - This option is incorrect because only **haemochromatosis** among these conditions is characteristically associated with intrahepatic cholestasis. - Neither galactosemia nor hypercalcemia typically present with cholestasis as a primary hepatic feature. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855.

Question 8: Micronodular cirrhosis is seen in all except:

A. Hemochromatosis
B. Chronic extrahepatic biliary obstruction
C. Chronic hepatitis B (Correct Answer)
D. Alcoholic liver disease

Explanation: ***Chronic hepatitis B*** - **Chronic hepatitis B** typically leads to **macronodular cirrhosis**, characterized by large, irregularly sized regenerative nodules separated by broad fibrous septa. - The liver architecture in macronodular cirrhosis is severely disrupted, with nodules often exceeding 3 mm in diameter. *Alcoholic liver disease* - **Alcoholic liver disease** commonly progresses to **micronodular cirrhosis**, which features small, uniformly sized regenerative nodules (typically <3 mm) surrounded by delicate fibrous septa [1]. - This pattern is due to the sustained effect of alcohol on hepatocytes and stellate cells, leading to continuous fibrosis. *Hemochromatosis* - **Hemochromatosis**, particularly advanced stages, often results in **micronodular cirrhosis** due to the progressive deposition of iron in hepatocytes, which causes chronic injury and fibrogenesis [1]. - The widespread iron deposition promotes diffuse fibrosis and the formation of numerous small regenerative nodules. *Chronic extrahepatic biliary obstruction* - **Chronic extrahepatic biliary obstruction** leads to **biliary cirrhosis**, which is typically **micronodular** in its early stages. - Prolonged cholestasis causes inflammation and periductal fibrosis, leading to the formation of small nodules and a characteristic "hobnail" appearance of the liver surface. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-396.

Question 9: Mallory bodies are typically seen in all of the following conditions except:

A. Primary biliary cirrhosis
B. Hepatocellular carcinoma
C. Neonatal hepatitis (Correct Answer)
D. Alcoholic liver disease

Explanation: ***Neonatal hepatitis (does not present with Mallory bodies)*** - Mallory bodies are typically absent in neonatal hepatitis, which often presents with **hepatocellular necrosis** but not the characteristic cytoplasmic inclusions. - The condition predominantly affects newborns and is associated with **viral infections** rather than alcoholic injury leading to Mallory bodies. *Hepatocellular carcinoma* - Hepatocellular carcinoma may show **Mallory bodies**, particularly in cases that have underlying liver disease such as cirrhosis [2][3]. - They may also appear in the setting of **alcohol-related liver conditions** that can predate the carcinoma [1][4]. *Alcoholic liver disease* - Mallory bodies are a classic finding in alcoholic liver disease, forming due to **cytoskeletal damage** from alcohol metabolism [1][4][5]. - The presence of these bodies, along with **steatosis**, indicates severe liver injury related to alcohol consumption [1][4]. *Indian childhood cirrhosis* - This condition is associated with Mallory bodies and represents **cholestatic liver disease** linked to **nutritional deficiencies** and malabsorption in children. - Histologically, it shares features with alcoholic liver disease, including the presence of these abnormal inclusions [1][4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 852. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 848-850.

Question 10: Which of the following conditions is associated with pathological copper pigmentation in the liver?

A. Wilson's disease (Correct Answer)
B. Pseudomelanin
C. Lipofuscin
D. None of the options

Explanation: ***None*** - This option indicates that there are no exceptions to the causes of pigmentation in the liver listed. - Pigmentation in the liver can indeed be caused by various factors including pseudomelanin, Wilson's disease, and lipofuscin [1,2]. *Pseudomelanin* - Pseudomelanin is associated with liver pigmentation caused by drugs or hormones, leading to a brown pigment. - It is a known cause of hepatic pigmentation; hence it is not an exception. *Wilson's disease* - Wilson's disease leads to copper accumulation in the liver [1], resulting in **greenish-brown pigmentation**. - This genetic disorder is a recognized cause of hepatic pigmentation, making it inappropriate as an exception [1]. *Lipofuscin* - Lipofuscin is an age-related pigment that accumulates in liver cells due to oxidative stress and cellular aging [2]. - Its presence is another cause of pigmentation and confirms that this option is not an exception. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 855-858. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 75.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free